Foyston, Gordon, & Payne Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$3.05M |
| 2 |
DuPont de Nemours
DD
|
+$2.33M |
| 3 |
UnitedHealth
UNH
|
+$2.29M |
| 4 |
Corteva
CTVA
|
+$1.48M |
| 5 |
C.H. Robinson
CHRW
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$11.1M |
| 2 |
Philip Morris
PM
|
+$6.1M |
| 3 |
Motorola Solutions
MSI
|
+$5.29M |
| 4 |
Microsoft
MSFT
|
+$4.26M |
| 5 |
Union Pacific
UNP
|
+$3.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.1% |
| 2 | Technology | 20.54% |
| 3 | Financials | 14.95% |
| 4 | Industrials | 13.08% |
| 5 | Consumer Staples | 12.03% |
Similar funds
Foyston, Gordon, & Payne's Q3 2019 Portfolio in Review
As of Q3 2019, Foyston, Gordon, & Payne held 61 positions worth $503M, down 6.2% from $536M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $38.5M in Q3 2019, closing 2 positions and reducing 34 holdings. Its most notable exit was Telefônica Brasil, an estimated $1.22M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
Against the trend, Foyston, Gordon, & Payne opened a new position in Vanguard S&P 500 ETF worth $331K.
- Foyston, Gordon, & Payne's largest Q3 2019 buy was Vanguard S&P 500 ETF: 1,213 shares worth $331K.
- Foyston, Gordon, & Payne added most to Cisco in Q3 2019, an estimated $3.05M increase.
- Foyston, Gordon, & Payne's biggest Q3 2019 reduction was Walgreens Boots Alliance, cutting an estimated $11.1M.
- Foyston, Gordon, & Payne fully exited Telefônica Brasil in Q3 2019, selling an estimated $1.22M.
- Foyston, Gordon, & Payne's ten largest holdings make up 54% of its $503M portfolio in Q3 2019.
- Foyston, Gordon, & Payne opened 1 new position and closed 2 in Q3 2019.
- Foyston, Gordon, & Payne's portfolio value fell 6.2% quarter-over-quarter to $503M.
Based on Foyston, Gordon, & Payne's 13F filing for Q3 2019, filed 14 Nov 2019.